Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company focused on marketed products and development candidates, announced its participat ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) fell 8.4% on Wednesday . The stock traded as low as $0.32 and last traded at $0.33. 80,811,016 shares traded hands during trading, ...

Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) dropped 7.8% during mid-day trading on Tuesday . The company traded as low as $0.33 and last traded at $0.33.

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a report published on Wednesday. The brokerage issued a hold rating on the stock. Tonix Pharmaceuticals ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report)’s stock price traded down 5.3% on Monday . The stock traded as low as $0.31 and last traded at $0.32. 28,828,476 shares changed ...

Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) were down 8.7% during trading on Friday . The company traded as low as $0.31 and last traded at $0.34. Approximately ...

Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.23) earnings per share (EPS) for the quarter ...